4.6 Article

Mucosal melanomas in the racially diverse population of California

Journal

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 76, Issue 2, Pages 250-257

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2016.08.007

Keywords

California; extracutaneous melanoma; melanoma; melanoma detection; mucosal melanoma; population-based database; race/ethnicity; screening

Categories

Funding

  1. National Cancer Institute's Surveillance, Epidemiology, and End Results Program [HHSN261201000140C, HHSN261201000035C, HHSN261201000034C]
  2. Centers for Disease Control and Prevention's National Program of Cancer Registries [U58DP003862]

Ask authors/readers for more resources

Background: Mucosal melanomas are rare, poorly understood neoplasms without a consensus standard of care. Objective: We sought to define mucosal melanoma tumor characteristics and the racial/ethnic attributes of patients with mucosal melanomas. Methods: We analyzed 130,920 cutaneous melanomas and 1919 mucosal melanomas recorded in the population-based California Cancer Registry from 1988 to 2013. Results: Although only 1% of melanomas occurring in nonHispanic whites were mucosal, other racial/ethnic groups had a higher proportion of mucosal melanomas (15% for Asian/Pacific Islanders, 9% for nonHispanic blacks, and 4% for Hispanics). Anorectal mucosal melanomas were most common in female Asian/Pacific Islanders, whereas genitourinary mucosal melanomas were highest in nonHispanic whites, and head and neck tumors were most common among Hispanics. Stage at presentation was not uniform among racial/ethnic groups, with Asian/Pacific Islanders having the highest rates of metastasis. Limitations: The lack of a standardized staging system for mucosal melanomas confounds classification and knowledge regarding metastasis. Small sample size limits comparative analysis across race, stage, site, and depth. Conclusion: Mucosal melanomas differ by race/ethnicity with regard to anatomic site, stage, and depth. Because early detection offers the best chance of increased survival, greater awareness will aid clinicians who care for patients at risk for these aggressive tumors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available